s.1manbetx

GSK makes $2.2B deal for RAPT and its food allergy candidate

The biopharma industry was hungry for an M&A deal during last week’s JP Morgan Healthcare Conference.

This report was first published by Endpoints News. To see the original version, click here

The biopharma industry was hungry for an M&A deal during last week’s JP Morgan Healthcare Conference.

It’s finally getting one.

您已阅读7%(216字),剩余93%(2940字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×